(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide | 1245927-53-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: (R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide
• 英文别名: 3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]benzimidazol-1-yl]thiophene-2-carboxamide
• CAS: 1245927-53-0
• 化学式: C₃₀H₃₂ClN₇O₂S
• 分子量: 590.149
• InChiKey: NXOJBDCDDRAJDO-HXUWFJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  41
• 可旋转键数：
  9
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  123
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  、 1-(2-bromoethyl)-4-methylpiperazine 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide
  参考文献：
  名称：

  Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties

  摘要：

  Potent inhibitors of PLK1 with acceptable solubility, mouse iv clearance, and reduced CYP450 inhibition were identified. Drug-like properties were improved using a heteroaryl ring as a functional handle for manipulation of inhibitors' physiochemical and DMPK properties. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.06.009

文献信息

• Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties
  作者：Tara R. Rheault、Kelly H. Donaldson、Jennifer G. Badiang-Alberti、Ronda G. Davis-Ward、C. Webb Andrews、Ramesh Bambal、Jeffrey R. Jackson、Mui Cheung

  DOI：10.1016/j.bmcl.2010.06.009

  日期：2010.8

  Potent inhibitors of PLK1 with acceptable solubility, mouse iv clearance, and reduced CYP450 inhibition were identified. Drug-like properties were improved using a heteroaryl ring as a functional handle for manipulation of inhibitors' physiochemical and DMPK properties. (C) 2010 Elsevier Ltd. All rights reserved.